Formosa Laboratories Inc
TWSE:4746

Watchlist Manager
Formosa Laboratories Inc Logo
Formosa Laboratories Inc
TWSE:4746
Watchlist
Price: 73.6 TWD 0.14% Market Closed
Market Cap: 8.9B TWD
Formosa Laboratories Inc
/
Balance Sheet
/
Cash Equivalents

Formosa Laboratories Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Formosa Laboratories Inc
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Formosa Laboratories Inc
TWSE:4746
Cash Equivalents
NT$69.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Y
YungShin Global Holding Corp
TWSE:3705
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ScinoPharm Taiwan Ltd
TWSE:1789
Cash Equivalents
NT$4B
CAGR 3-Years
1%
CAGR 5-Years
7%
CAGR 10-Years
11%
S
SCI Pharmtech Inc
TWSE:4119
Cash Equivalents
NT$448.1m
CAGR 3-Years
152%
CAGR 5-Years
6%
CAGR 10-Years
7%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Standard Chem & Pharm Co Ltd
TWSE:1720
Cash Equivalents
NT$596.9m
CAGR 3-Years
-27%
CAGR 5-Years
0%
CAGR 10-Years
12%

Formosa Laboratories Inc
Glance View

Market Cap
8.9B TWD
Industry
Pharmaceuticals

Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.

Intrinsic Value
115.9 TWD
Undervaluation 36%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Formosa Laboratories Inc's Cash Equivalents?
Cash Equivalents
69.5m TWD

Based on the financial report for Dec 31, 2024, Formosa Laboratories Inc's Cash Equivalents amounts to 69.5m TWD.

What is Formosa Laboratories Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 1Y
-69%

Over the last year, the Cash Equivalents growth was -69%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 241,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.